Abstract

Chirag Warty*, Dr. Manaswi Rajurkar

ABSTRACT

The human immune system is intricately regulated by a network of biochemical, neurological, and endocrine interactions. In recent years, growing interest in transdermal phytotherapeutics and gut-immune axis regulation has prompted exploration of alternative delivery mechanisms for systemic immunomodulation. One such ancient yet underutilized approach is Nabhi therapy - the application of therapeutic oils to the periumbilical (navel) region as described in classical Ayurvedic texts. This paper investigates the physiological rationale, biochemical pathways, and immunological outcomes associated with the application of Sea Buckthorn (Hippophae rhamnoides) oil to the navel, as practiced in Ayurvedic transdermal Nabhi oil therapies. The navel region possesses a dense vascular, lymphatic, and neurological network, making it a strategic site for transdermal delivery of lipophilic compounds. Sea Buckthorn oil, rich in Omega-3, 6, 7 and 9 fatty acids, carotenoids, tocopherols, and phytosterols, has demonstrated potent immunomodulatory, anti-inflammatory, and antioxidant effects in both clinical and experimental settings. This paper hypothesizes that its application via the Nabhi enhances systemic immunity by delivering bioactive compounds through lymphatic channels, modulating gut-associated lymphoid tissue (GALT), and stimulating the vagus nerve, which is implicated in both immune regulation and inflammation control. Furthermore, Sea Buckthorn has been shown to regulate inflammatory cytokines such as TNF-α, IL-6, and IL-1β, while enhancing natural killer (NK) cell activity, improving mucosal immunity, and restoring redox balance - outcomes that are desirable in conditions involving immune fatigue, chronic inflammation, or post-viral recovery. Ayurvedic principles support this modality through the classification of Nabhi as a Marma point that influences Agni (digestive fire), Ojas (immunity), and Rasa-Rakta dhatu (nutrient and blood tissue layers). By integrating modern biomedical research with Ayurvedic pharmacology, this paper proposes Nabhi therapy as a viable adjunct or standalone route for immune enhancement and inflammation reduction, particularly in populations seeking non-oral, non-invasive, and integrative interventions. The findings support further exploration through pilot trials and quantitative biomarker studies to validate efficacy and mechanistic insights.